San Diego, CA, United States of America

Lurdes Duarte

This inventor holds 1 USPTO granted patent. Top assignee: Sorriso Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lurdes Duarte. Retrieved from https://idiyas.com/inventor/lurdes-duarte-ysh7f4fo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lurdes Duarte: Innovator in Pharmaceutical Compositions

Introduction

Lurdes Duarte is a prominent inventor based in San Diego, California. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work at Sorriso Pharmaceuticals, Inc. Her dedication to advancing medical science is evident in her patent portfolio.

Latest Patents

Lurdes holds a patent for "Compositions," which showcases her expertise in developing new pharmaceutical formulations. This patent reflects her commitment to improving health outcomes through innovative solutions.

Career Highlights

Throughout her career, Lurdes has demonstrated exceptional skill and creativity in her work. Her role at Sorriso Pharmaceuticals, Inc. has allowed her to collaborate with other professionals in the industry, further enhancing her contributions to pharmaceutical research and development.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Lurdes Duarte is a remarkable inventor whose work in pharmaceutical compositions has the potential to impact the industry significantly. Her innovative spirit and dedication to her field continue to inspire others in the realm of medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…